Cookie Policy

What is a Cookie?

Cookies are small text files that are placed on your computer by websites that you visit. They are widely used in order to make websites work, or work more efficiently, as well as to provide information to the owners of the site.

How we use Cookies

We use cookies to control how our Website pages look, to remember your preferences, to control access to secure parts of the Website and for some advanced functionality. Where personal information is required (for registration purposes, etc.), we will make it clear when we collect it, we will explain what we intend to do with it, and you have the option to not supply it. If you do not wish to use cookies, then please disable them using your browser settings.

Cookies used by this Website

Cookies, whether session or persistent, are also described as first-party or third-party cookies. Cookies relating to content coming from the page’s primary server are first-party cookies; where the web page’s content does not come from the page’s primary server, they are referred to as third-party cookies. Listed below are the cookies that we use to manage our Website delivery to your browser:

  • Session cookies

Specific information on the Cookies used

Session cookies

A session cookie enhances the user experience when using the Website. These enable you to carry out some essential functions on our site, such as maintaining log-in details for the session or transaction. They also help by minimising the need to transfer information across the internet. They are not stored on your computer and they expire when you terminate your browser session. 

More information on disabling cookies can be found on https://www.aboutcookies.org.uk/

Last Updated: June 2025

Intended Use

Rejoyn is a digital therapeutic intended for the treatment of depressive disorder episodes in adults. It is intended to be used alongside usual care and supported by a Healthcare Professional.
Please read the Instructions For Use for Rejoyn.

Adverse Events

Adverse events should be reported. Reporting forms and information can be found at
www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. To report Rejoyn side effects or quality complaints, contact +44 (0) 808 168 6726 or OPUKSafety@otsuka.co.uk

Download on the App StoreGet It On: Google Playstore

Access code required

Please see How to Access Rejoyn for more info

Otsuka

This webpage is for the general public with an interest in Rejoyn, an app developed by Otsuka Pharmaceutical Europe Ltd.
Please note that Rejoyn requires a prescription or referral from a healthcare professional.

Date of preparation: June 2025
UK-152-2500021 (v1.0)

Necessary Cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.